Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 ...

Unaudited Estimated Ranges Consistent with Previous Financial Guidance  Raises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, ...

Former Bristol Myers Squibb, Goldman Sachs, and Barclays executive brings deep expertise in corporate strategy, partnership development, public and private financial markets, and management as the ...